A detailed history of Royal Bank Of Canada transactions in Vaccitech PLC stock. As of the latest transaction made, Royal Bank Of Canada holds 105 shares of VACC stock, worth $358. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105
Holding current value
$358
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
N/A
105 New
105 $0
Q2 2024

Aug 14, 2024

BUY
N/A
4,065 New
4,065 $13,000
Q3 2023

Nov 14, 2023

BUY
$1.68 - $3.16 $1,680 - $3,160
1,000 New
1,000 $3,000

Others Institutions Holding VACC

About Vaccitech plc


  • Ticker VACC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,216,200
  • Market Cap $127M
  • Description
  • Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B...
More about VACC
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.